Vanderpoel, Julie
Emond, Bruno http://orcid.org/0000-0002-0060-765X
Ghelerter, Isabelle
Milbers, Katherine
Lafeuille, Marie-Hélène
Lefebvre, Patrick
Ellis, Lorie A.
Funding for this research was provided by:
Janssen Scientific Affairs
Article History
Accepted: 6 March 2023
First Online: 19 April 2023
Declarations
:
: This work was sponsored by Janssen Scientific Affairs, LLC. The sponsor was involved in the study design, interpretation of results, manuscript preparation, and publication decisions.
: BE, MHL and PL are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Janssen Scientific Affairs, LLC, which funded the development and conduct of this study and manuscript. JV and LE are employees of Janssen Scientific Affairs, LLC and stockholders of Johnson & Johnson. IG and KM were employees of Analysis Group, Inc., at the time the study was conducted.
: The data that support the findings of this study are available from IBM but restrictions apply to the availability of these data, which were used pursuant to a data use agreement. The data are available through requests made directly to IBM, subject to IBM’s requirements for data access.
: All analyses were conducted using SAS Enterprise Guide 7.1 (SAS Institute, Cary, NC, USA). The SAS programs are proprietary materials of Analysis Group, Inc.; therefore, restrictions apply to the access of these codes, which cannot be made available publicly.
: BE, IG, KM, MHL, and PL contributed to study conception and design, collection of data, and data analysis and interpretation. JV and LE contributed to study conception and design, and data analysis and interpretation. All authors were involved in drafting, reviewing, and approving the final content of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.